Polycystic Ovary Syndrome and Pelvic Floor Dysfunction: A Narrative Review

References

• Dheresa M, Worku A, Oljira L, Mengiste B, Assefa N, Berhane Y. One in five women suffer from pelvic floor disorders in Kersa district Eastern Ethiopia: a community-based study. BMC Womens Health. 2018;18(1):95. doi:10.1186/s12905-018-0585-129902997
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Simbar M, Abedini M. Reproductive morbidity among Iranian women; issues often inappropriately addressed in health seeking behaviors. BMC Public Health. 2011;11(1):863. doi:10.1186/1471-2458-11-86322078752
   PubMed Web of Science ®Google Scholar
• Jundt K, Peschers U, Kentenich H. The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int. 2015;112(33–34):564. doi:10.3238/arztebl.2015.056426356560
   PubMed Web of Science ®Google Scholar
• Marques A, Stothers L, Macnab A. The status of pelvic floor muscle training for women. Can Urol Assoc J. 2010;4(6):419. doi:10.5489/cuaj.1002621191506
   PubMed Web of Science ®Google Scholar
• Bureau M, Carlson KV. Pelvic organ prolapse: a primer for urologists. Can Urol Assoc J. 2017;11(6Suppl2):S125. doi:10.5489/cuaj.463428616110
   PubMed Web of Science ®Google Scholar
• Fünfgeld C, Stehle M, Henne B, et al. Quality of life and pelvic organ prolapse-related symptoms after pelvic floor reconstruction with a titanized polypropylene mesh for cystocele: long-term results in a 36 month follow-up. Pelviperineology. 2018;105.
   Google Scholar
• Yuk J-S, Lee JH, Hur J-Y, Shin J-H. The prevalence and treatment pattern of clinically diagnosed pelvic organ prolapse: a korean national health insurance database-based cross-sectional study 2009–2015. Sci Rep. 2018;8(1):1–6. doi:10.1038/s41598-018-19692-529311619
   PubMed Web of Science ®Google Scholar
• Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric. 2019;22(3):217–222. doi:10.1080/13697137.2018.154326330572737
   PubMed Web of Science ®Google Scholar
• Kepenekci I, Keskinkilic B, Akinsu F, et al. Prevalence of pelvic floor disorders in the female population and the impact of age, mode of delivery, and parity. Dis Colon Rectum. 2011;54(1):85–94. doi:10.1007/DCR.0b013e3181fd235621160318
   PubMed Web of Science ®Google Scholar
• Bodner-Adler B, Kimberger O, Laml T, et al. Prevalence and risk factors for pelvic floor disorders during early and late pregnancy in a cohort of Austrian women. Arch Gynecol Obstet. 2019;300(5):1325–1330. doi:10.1007/s00404-019-05311-931599348
   PubMed Web of Science ®Google Scholar
• Mushkat Y, Bukovsky I, Langer R. Female urinary stress incontinence-does it have familial prevalence? Am J Obstet Gynecol. 1996;174(2):617–619. doi:10.1016/S0002-9378(96)70437-48623794
   PubMed Web of Science ®Google Scholar
• Rohr G, Kragstrup J, Gaist D, Christensen K. Genetic and environmental influences on urinary incontinence: a Danish population‐based twin study of middle‐aged and elderly women. Acta Obstet Gynecol Scand. 2004;83(10):978. doi:10.1111/j.0001-6349.2004.00635.x15453898
   PubMed Web of Science ®Google Scholar
• Cundiff GW, Harris RL, Coates KW, Bump RC. Clinical predictors of urinary incontinence in women. Am J Obstet Gynecol. 1997;177(2):262–267. doi:10.1016/S0002-9378(97)70185-69290438
   PubMed Web of Science ®Google Scholar
• Lin AS, Carrier S, Morgan DM, Lue TF. Effect of simulated birth trauma on the urinary continence mechanism in the rat. Urology. 1998;52(1):143–151. doi:10.1152/ajprenal.00230.20179671889
   PubMed Web of Science ®Google Scholar
• Copas P, Bukovsky A, Asbury B, Elder RF, Caudle MR. Estrogen, progesterone, and androgen receptor expression in levator ani muscle and fascia. J Wom Health Gend Base Med. 2001;10(8):785–795. doi:10.1089/15246090152636541
   Google Scholar
• Chen Y, Hua K. Expression of androgen receptor in the vaginal wall and cardinal ligament of patients with pelvic organ prolapse. Zhonghua Yi Xue Za Zhi. 2008;88(41):2920–2923.19080100
   PubMedGoogle Scholar
• Sirmans SM, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6:1. doi:10.2147/CLEP.S37559
   Web of Science ®Google Scholar
• Wolf WM, Wattick RA, Kinkade ON, Olfert MD. Geographical prevalence of polycystic ovary syndrome as determined by region and race/ethnicity. Int J Environ Res Public Health. 2018;15(11):2589. doi:10.3390/ijerph15112589
   PubMed Web of Science ®Google Scholar
• Ramanand SJ, Ghongane BB, Ramanand JB, Patwardhan MH, Ghanghas RR, Jain SS. Clinical characteristics of polycystic ovary syndrome in Indian women. Indian J Endocrinol Metab. 2013;17(1):138. doi:10.4103/2230-8210.10785823776867
   PubMedGoogle Scholar
• Eshre TR, Group A-Spcw. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
   Web of Science ®Google Scholar
• Daniilidis A, Dinas K. Long term health consequences of polycystic ovarian syndrome: a review analysis. Hippokratia. 2009;13(2):90.19561777
   PubMed Web of Science ®Google Scholar
• Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010;8(1):41. doi:10.1186/1741-7015-8-4120591140
   PubMed Web of Science ®Google Scholar
• Taghavi SA, Bazarganipour F, Allan H, et al. Pelvic floor dysfunction and polycystic ovary syndrome. Hum Fertil. 2017;20(4):262–267. doi:10.1080/14647273.2017.1292003
   PubMed Web of Science ®Google Scholar
• Antônio FI, Bo K, Ferriani RA, de Sá MFS, de Sá Rosa ACJ, Ferreira CHJ. Pelvic floor muscle strength and urinary incontinence in hyperandrogenic women with polycystic ovary syndrome. Int Urogynecol J. 2013;24(10):1709–1714. doi:10.1007/s00192-013-2095-x23575700
   PubMed Web of Science ®Google Scholar
• Fowler CJ, Christmas TJ, Chapple CR, Parkhouse HF, Kirby RS, Jacobs HS. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ. 1988;297(6661):1436–1438. doi:10.1136/bmj.297.6661.14363147005
   PubMed Web of Science ®Google Scholar
• Ghetti C, Skoczylas LC, Oliphant SS, Nikolajski C, Lowder JL. The emotional burden of pelvic organ prolapse in women seeking treatment: a qualitative study. Female Pelvic Med Reconstr Surg. 2015;21(6):332. doi:10.1097/SPV.000000000000019026506161
   PubMed Web of Science ®Google Scholar
• Twiss C, Triaca V, Bergman J, Rodríguez LV. The epidemiology, social burden, and genetics of pelvic organ prolapse. Curr Bladder Dysfunct Rep. 2008;3(2):90–94. doi:10.1007/s11884-008-0014-7
   Google Scholar
• Aoki Y, Brown HW, Brubaker L, Cornu JN, Daly JO, Cartwright R. Urinary incontinence in women. Nat Rev Dis Primers. 2017;3(1):1–20. doi:10.1038/nrdp.2017.42
   Web of Science ®Google Scholar
• Subramanian D, Szwarcensztein K, Mauskopf JA, Slack MC. Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and England. Eur J Obstet Gynecol Reprod Biol. 2009;144(2):177–181. doi:10.1016/j.ejogrb.2009.03.00419414209
   PubMed Web of Science ®Google Scholar
• Subak LL, Waetjen LE, Van Den Eeden S, Thom DH, Vittinghoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98(4):646–651. doi:10.1016/S0029-7844(01)01472-711576582
   PubMed Web of Science ®Google Scholar
• Hakimi S, Simbar M, Tehrani FR. Perceived concerns of Azeri menopausal women in Iran. Iran Red Crescent Med J. 2014;16:5. doi:10.5812/ircmj.11771
   Web of Science ®Google Scholar
• Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4(1):5. doi:10.1186/s41073-019-0064-830962953
   PubMedGoogle Scholar
• Davila GW. Hormonal influences on the pelvic floor In: Davila GW, Ghoniem GM, Wexner SD, editors. Pelvic Floor Dysfunction. London: Springer; 2008:295–299. doi:10.1007/978-1-84800-348-4_50
   Google Scholar
• Ho MH, Bhatia NN, Bhasin S. Anabolic effects of androgens on muscles of female pelvic floor and lower urinary tract. Curr Opin Obstet Gynecol. 2004;16(5):405–409. doi:10.1097/00001703-200410000-0000915353950
   PubMed Web of Science ®Google Scholar
• Kim MM, Kreydin EI. The association of serum testosterone levels and urinary incontinence in women. J Urol. 2018;199(2):522–527. doi:10.1016/j.juro.2017.08.09328847480
   PubMed Web of Science ®Google Scholar
• Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol. 2001;98(3):445–449. doi:10.1016/s0029-7844(01)01450-811530127
   PubMed Web of Science ®Google Scholar
• Sinha-Hikim I, Roth SM, Lee MI, Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol. 2003;285(1):E197–E205. doi:10.1152/ajpendo.00370.2002
   PubMed Web of Science ®Google Scholar
• Kogure GS, Silva RC, Miranda-Furtado CL, et al. Hyperandrogenism Enhances muscle strength after progressive resistance training, independent of body composition, in women with polycystic ovary syndrome. J Strength Cond Res. 2018;32(9):2642–2651. doi:10.1519/JSC.000000000000271429927897
   PubMed Web of Science ®Google Scholar
• Teleman PM, Persson J, Mattiasson A, Samsioe G. The relation between urinary incontinence and steroid hormone levels in perimenopausal women. A report from the Women’s Health in the Lund Area (WHILA) study. Acta Obstet Gynecol Scand. 2009;88(8):927–932. doi:10.1080/0001634090311798619579140
   PubMed Web of Science ®Google Scholar
• Nader S, Diamanti-Kandarakis E. Polycystic ovary syndrome, oral contraceptives and metabolic issues: new perspectives and a unifying hypothesis. Hum Reprod. 2007;22:317. doi:10.1093/humrep/del40717099212
   PubMed Web of Science ®Google Scholar
• Townsend MK, Curhan GC, Resnick NM, Grodstein F. Oral contraceptive use and incident urinary incontinence in premenopausal women. J Urol. 2009;181(5):2170–2175. doi:10.1016/j.juro.2009.01.04019296979
   PubMed Web of Science ®Google Scholar
• Iliadou A, Milsom I, Pedersen NL, Altman D. Risk of urinary incontinence symptoms in oral contraceptive users: a national cohort study from the Swedish Twin Register. Fertil Steril. 2009;92(2):428–433. doi:10.1016/j.fertnstert.2008.07.00218706546
   PubMed Web of Science ®Google Scholar
• Hextall A, Bidmead J, Cardozo L, Hooper R. The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. BJOG. 2001;108(11):1193–1196. doi:10.1111/j.1471-0528.2003.00280.x11762662
   PubMed Web of Science ®Google Scholar
• Edwall L, Carlström K, Jonasson AF. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn. 2007;26(3):410–415. doi:10.1002/nau.2033517266139
   PubMed Web of Science ®Google Scholar
• Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520. doi:10.1210/er.2015-110427459230
   PubMed Web of Science ®Google Scholar
• Barnes RB. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies. J Endocrinol Invest. 1998;21(9):567–579. doi:10.1007/bf033507829856411
   PubMed Web of Science ®Google Scholar
• Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM. Is there a difference in the electromyographic activity of the pelvic floor muscles across the phases of the menstrual cycle? J Phys Ther Sci. 2015;27(7):2233–2237. doi:10.1589/jpts.27.223326311960
   PubMedGoogle Scholar
• Montezuma T, Antônio FI, Silva A, Sá M, Ferriani RA, Ferreira CHJ. Assessment of symptoms of urinary incontinence in women with polycystic ovary syndrome. Clinics. 2011;66(11):1911–1915. doi:10.1590/S1807-5932201100110001022086521
   PubMed Web of Science ®Google Scholar
• Micussi MT, Freitas RP, Varella L, Soares EM, Lemos TM, Maranhão TM. Relationship between pelvic floor muscle and hormone levels in polycystic ovary syndrome. Neurourol Urodyn. 2016;35(7):780–785. doi:10.1002/nau.2281726288062
   PubMed Web of Science ®Google Scholar
• Lim SS, Davies M, Norman RJ, Moran L. Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–637. doi:10.1093/humupd/dms03022767467
   PubMed Web of Science ®Google Scholar
• Legro RS. Obesity and PCOS: implications for diagnosis and treatment. Paper presented at: Seminars in reproductive medicine; 2012. doi: 10.1055/s-0032-1328878
   Google Scholar
• Pomian A, Lisik W, Kosieradzki M, Barcz E. Obesity and pelvic floor disorders: a review of the literature. Med Sci Monit. 2016;22:1880. doi:10.12659/MSM.89633127255341
   PubMed Web of Science ®Google Scholar
• Cummings J, Rodning C. Urinary stress incontinence among obese women: review of pathophysiology therapy. Int Urogynecol J. 2000;11(1):41–44. doi:10.1007/s001920050008
   Web of Science ®Google Scholar
• Giri A, Hartmann KE, Hellwege JN, Edwards DRV, Edwards TL. Obesity and pelvic organ prolapse: a systematic review and meta-analysis of observational studies. Am J Obstet Gynecol. 2017;217(1):11–26. e13. doi:10.1016/j.ajog.2017.01.03928188775
   PubMed Web of Science ®Google Scholar
• Subak LL, Richter HE, Hunskaar S. Obesity and urinary incontinence: epidemiology and clinical research update. J Urol. 2009;182(6S):S2–S7. doi:10.1016/j.juro.2009.08.07119846133
   PubMed Web of Science ®Google Scholar
• Lee UJ, Kerkhof MH, Van Leijsen SA, Heesakkers JP. Obesity and pelvic organ prolapse. Curr Opin Urol. 2017;27(5):428–434. doi:10.1097/MOU.000000000000042828700456
   PubMed Web of Science ®Google Scholar
• de Melo MV, Micussi MABC, de Medeiros RD, Cobucci RN, de Oliveira Maranhão T, Gonçalves A. Pelvic floor muscle thickness in women with polycystic ovary syndrome. Clin Exp Obstet Gynecol. 2018;45(6):2018. doi:10.12891/ceog4113.2018
   Web of Science ®Google Scholar
• Gorbachinsky I, Akpinar H, Assimos DG. Metabolic syndrome and urologic diseases. Rev Urol. 2010;12(4):e157.21234260
   PubMedGoogle Scholar
• Lim S, Kakoly N, Tan J, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta‐analysis and meta‐regression. Obes Rev. 2019;20(2):339–352. doi:10.1111/obr.1276230339316
   PubMed Web of Science ®Google Scholar
• Rogowski A, Bienkowski P, Tarwacki D, et al. Association between metabolic syndrome and pelvic organ prolapse severity. Int Urogynecol J. 2015;26(4):563–568. doi:10.1007/s00192-014-2468-925047898
   PubMed Web of Science ®Google Scholar
• Joham AE, Boyle JA, Zoungas S, Teede HJ. Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity. Am J Hypertens. 2015;28(7):847–851. doi:10.1093/ajh/hpu25125542625
   PubMed Web of Science ®Google Scholar
• Yoon BI, Han K-D, Lee KW, et al. Insulin resistance is associated with prevalence of physician-diagnosed urinary incontinence in postmenopausal non-diabetic adult women: data from the Fourth Korea National Health and Nutrition Examination Survey. PLoS One. 2015;11:10. doi:10.1371/journal.pone.0141720
   Web of Science ®Google Scholar
• Phelan S, Grodstein F, Brown JS. Clinical research in diabetes and urinary incontinence: what we know and need to know. J Urol. 2009;182(6):S14–S17. doi:10.1016/j.juro.2009.07.08719846135
   PubMed Web of Science ®Google Scholar
• Legro RS. Type 2 diabetes and polycystic ovary syndrome. Fertil Steril. 2006;86:S16–S17. doi:10.1016/j.fertnstert.2006.04.01016798276
   PubMed Web of Science ®Google Scholar
• Gava G, Alvisi S, Mancini I, Seracchioli R, Meriggiola MC. Prevalence of metabolic syndrome and its components in women with and without pelvic organ prolapse and its association with prolapse severity according to the pelvic organ prolapse quantification system. Int Urogynecol J. 2019;30(11):1911–1917. doi:10.1007/s00192-018-3840-y30539201
   PubMed Web of Science ®Google Scholar
• Isık H, Aynıoglu O, Sahbaz A, Selimoglu R, Timur H, Harma M. Are hypertension and diabetes mellitus risk factors for pelvic organ prolapse? Eur J Obstet Gynecol Reprod Biol. 2016;197:59–62. doi:10.1016/j.ejogrb.2015.11.03526706923
   PubMed Web of Science ®Google Scholar
• Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS prevalence study. Clin Endocrinol (Oxf). 2014;81(1):93–99. doi:10.1111/cen.1240624428207
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Rashidi H, Khomami MB, Tohidi M, Azizi F. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran. Reprod Biol Endocrinol. 2014;12(1):89. doi:10.1186/1477-7827-12-8925224635
   PubMed Web of Science ®Google Scholar
• Micussi MT, Freitas RP, Angelo PH, Soares EM, Lemos TM, Maranhão TM. Evaluation of the relationship between the pelvic floor muscles and insulin resistance. Diabetes Metab Syndr Obes. 2015;8:409. doi:10.2147/DMSO.S8581626357485
   PubMed Web of Science ®Google Scholar
• Sachdeva G, Gainder S, Suri V, Sachdeva N, Chopra S. Comparison of the different PCOS phenotypes based on clinical metabolic, and hormonal profile, and their response to clomiphene. Indian J Endocrinol Metab. 2019;23(3):326. doi:10.4103/ijem.IJEM_30_1931641635
   PubMedGoogle Scholar
• Głuszak O, Stopińska-Głuszak U, Glinicki P, et al. Phenotype and metabolic disorders in polycystic ovary syndrome. ISRN Endocrinol. 2012;2012:1–7. doi:10.5402/2012/569862
   Google Scholar
• Weintraub AY, Glinter H, Marcus-Braun N. Narrative review of the epidemiology, diagnosis and pathophysiology of pelvic organ prolapse. Int Braz J Urol. 2020;46(1):5–14. doi:10.1590/S1677-5538.IBJU.2018.058131851453
   PubMed Web of Science ®Google Scholar
• Qin JZ, Pang LH, Li MJ, Fan XJ, Huang RD, Chen HY. Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrin. 2013;11(1):56. doi:10.1186/1477-7827-11-56
   Web of Science ®Google Scholar
• Zhao Y, Zou L, Xiao M, Tang W, Niu H-Y, Qiao F-Y. Effect of different delivery modes on the short-term strength of the pelvic floor muscle in Chinese primipara. BMC Pregnancy Childbirth. 2018;18(1):275. doi:10.1186/s12884-018-1918-729970030
   PubMed Web of Science ®Google Scholar
• Memon HU, Handa VL. Vaginal childbirth and pelvic floor disorders. Womens Health. 2013;9(3):265–277. doi:10.2217/whe.13.17
   Google Scholar
• Yu C-J, Hsu -C-C, Lee W-C, Chiang P-H, Chuang Y-C. Medical diseases affecting lower urinary tract function. Urol Sci. 2013;24(2):41–45. doi:10.1016/j.urols.2013.04.004
   Google Scholar
• Zhao L, Zhu Z, Lou H, et al. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget. 2016;7(23):33715. doi:10.18632/oncotarget.955327220885
   PubMedGoogle Scholar
• Yao K, Bian C, Zhao X. Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: aggravated complication of pregnancy. Exp Ther Med. 2017;14(2):1271–1276. doi:10.3892/etm.2017.464228810587
   PubMed Web of Science ®Google Scholar